Target Price | CHF17.00 |
Price | CHF10.20 |
Potential |
66.67%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target Medmix 2026 .
The average Medmix target price is CHF17.00.
This is
66.67%
register free of charge
CHF20.00
96.08%
register free of charge
CHF13.00
27.45%
register free of charge
|
|
A rating was issued by 3 analysts: 3 Analysts recommend Medmix to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Medmix stock has an average upside potential 2026 of
66.67%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million CHF | 483.90 | 488.49 |
0.55% | 0.95% | |
EBITDA Margin | 15.35% | 17.79% |
9.23% | 15.86% | |
Net Margin | -1.52% | 2.49% |
1,910.04% | 264.11% |
3 Analysts have issued a sales forecast Medmix 2025 . The average Medmix sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Medmix EBITDA forecast 2025. The average Medmix EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Medmix Analysts have issued a net profit forecast 2025. The average Medmix net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share CHF | -0.18 | 0.30 |
1,900.00% | 266.67% | |
P/E | 35.51 | |
EV/Sales | 1.33 |
3 Analysts have issued a Medmix forecast for earnings per share. The average Medmix EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.